Fylde and Wyre CCG Medicines Optimisation

Click each header to expand its content

Fylde and Wyre medicines RAG list

Application forms

Medicines commissioning policies

Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB185
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB119
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB130
Brimonidine For Erythema Of Rosacea 0.1 MB117
Certolizumab For Psoriatic Arthritis 0.1 MB100
Co-Proxamol For pain management 0.3 MB240
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB124
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB123
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB114
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB88
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB236
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB85
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB95
Denosumab for GIO 0.2 MB66
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB132
Eflornithine-cream-for-facial-hirsutism 0.2 MB122
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB78
Eslicarbazepine For Focal Seizures 0.1 MB104
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB113
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB118
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB79
Gluten-Free-Food-Products 0.3 MB124
Guanfacine-for-ADHD 0.3 MB100
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB99
Insulin Degludec And Liraglutide 0.2 MB99
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB110
Insulin-Degludec-for-DM 0.3 MB115
Insulin-Detemir-for-DM 0.2 MB84
Insuline-Glargine-for-T1DM 0.3 MB94
Insuline-Glargine-for-T2DM 0.3 MB97
Invicorp-injection-for-erectile-dysfunction 0.3 MB130
Ivermectin-cream-for-rosacea 0.3 MB111
JIA Policy For Adults (Version 1.0) 0.2 MB82
Lamotrigine-for-trigeminal-neuralgia 0.3 MB107
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB126
Levonorgestrel 13.5mg IUD 0.3 MB86
Lidocaine Plasters For PHN 0.2 MB98
Lidocaine-plasters-for-unlicensed-indications 0.3 MB175
Liothyronine-for-refractory-hypothyroidism 0.2 MB139
Liraglutide-for-obesity 0.3 MB108
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB121
Lisdexamfetamine-for-ADHD-update 0.3 MB100
Lurasidone-for-Schizophrenia 0.3 MB125
Magnaspartate For Hypomagnesaemia 0.3 MB200
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB93
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB76
Midazolam-Epistatus-for-seizures 0.2 MB132
Opicapone-for-Parkinsons-disease-v2 0.5 MB125
Ospemifene for VVA 0.2 MB136
Oxycodone-Naloxone-for-Restless-legs 0.3 MB90
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB324
Patiromer-for-hyperkalaemia 0.3 MB99
Patiromer-for-hyperkalaemia 2 0.3 MB118
Phosphodiesterase Type-5 Inhibitors 0.2 MB89
Pitolisant-for-Narcolepsyv2 0.3 MB101
Policy On Brand Inhaler Prescribing 0.3 MB138
Probiotics And VSL 0.3 MB101
Relvar Ellipta for COPD and asthma in adults 63 KB84
Rituximab-for-AIHA 0.4 MB118
Rituximab-for-ITP 0.4 MB99
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB105
Safinamide-for-Parkinsons-disease 0.3 MB123
Second Line Anti-TNF For PsA 0.2 MB105
Second-generation-LA-antipsychotics 0.3 MB120
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB93
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB95
Semaglutide for type 2 DM 0.2 MB68
Silk Garments For Eczema And Dermatitis 0.2 MB89
Simbrinza for chronic open angle glaucoma 0.1 MB80
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB114
Spironolactone For Acne 0.1 MB121
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB98
Tadalafil daily 0.3 MB132
Tapentadol for neuropathic pain in non-palliative care 0.4 MB115
Tapentadol for non-specific pain 0.2 MB98
Testosterone For Female Sexual Dysfunction 0.1 MB75
Tiotropium For Asthma 0.2 MB83
Trelegy inhaler for COPD 0.3 MB124
Trimbow inhaler for COPD 0.4 MB122
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB104
Umeclidinium For COPD 0.2 MB76
Vedolizumab For Crohn's Disease 0.2 MB65
Vitamins (inc Renavit) For Dialysis 0.3 MB128
Waterproof Cast Cover Policy 0.1 MB204
Xonvea for nausea and vomiting in pregnancy 0.1 MB68

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

Algorithm-for-antihyperglycaemic-therapy-in-adults-with-type-II-v1.5[3] 0.5 MB16
Asthma treatment guideline for children 0.4 MB3
Azathioprine-Mercaptopurine-SCG-Version 0.2 MB206
BGTS and Meters Guideline Nov16 1.2 MB660
Cannabis-based-medicinal-products-for-pain-POSITION-STATEMENT-version-1.1[1] 0.3 MB16
Ciclosporin-SCG-Version 0.2 MB117
Commissioining Policy For Nutritional Supp Post Bariatirc Surgery Apr13 83 KB110
Conditions-for-which-OTC-items-should-not-routinely-be-prescribed-in-pri .. 0.9 MB161
Dalteparin SCG 2018 0.2 MB107
Electronic-Repeat-Dispensing-guideline 1.7 MB725
Emollient-Guideline-May-2017 0.2 MB563
Flash Glucose Monitoring policy - L&SC 0.2 MB80
Flowchart-for-Vitamin-D-Deficiency-in-Primary-Care 0.3 MB309
Guidance to support the implementation of the valproate PREVENT programme 0.5 MB152
Guidance-for-7-day-prescriptions-FWCCG-Apr2018 0.5 MB188
Lancashire and South Cumbria Self-Care and Acces to OTC Medicines – Temp... 83 KB3
Leflunomide-SCG-Version 0.2 MB107
LSCMMG OTC Items that Should not be Routinely Prescribed in Primary Care... 0.2 MB26
MDS Briefing Doc Oct 13 43 KB78
Methotrexate-SCG-Version 0.2 MB202
Mgt-of-Infection-Primary-Care-Guidance-January-2017-version2 0.7 MB551
Patient information - Emollients.steroid.barrier creams 0.2 MB64
Patient information - Emollients.steroid.barrier creams 0.2 MB162
Patient information - spacer devices 0.2 MB101
Patient information - spacer devices 0.2 MB66
Penicillamine-SCG-Version 0.2 MB88
Policy Unlicensed Herbal Vits Mins Supplements 2013 77 KB63
Position Statement OPIOID PRESCRIBING max dose Final Version 1.1 0.1 MB25
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB10
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB12
RMOC-Liothyronine-Guidance-v2.0-final-1 0.5 MB69
Sodium-Aurothiomalate-SCG-Version 0.2 MB17
Sulfasalazine 0.2 MB151
Testosterone-Shared-Care-Guideline-Version-1.2[1] 0.3 MB13
Wound Care Formulary 8.2 MB550

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – Started July 2019
  • Fencino (Fentanyl) – Started April 2016
  • Firmagon (Degarelix) – Started September 2016
  • Januvia (Sitagliptin) – Started September 2018
  • Lixiana (Edoxaban) – Started February 2018
  • Longtec (Oxycodone SR) – Started July 2019
  • Sereflo (Fluticasone / Salmeterol) – Started July 2019
  • Seretide (Fluticasone / Salmeterol) – Started April 2016
  • Xarelto (Rivaroxaban) – Started October 2019
  • Zoladex (Goserelin) – Started January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 18 December 2019 at 11:14 by Senior communications and engagement officer N